Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies

[1]  H. Akiyama,et al.  Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using α-synuclein-immunohistochemistry , 2000, Neuroscience Letters.

[2]  D. Clayton,et al.  Synucleins in synaptic plasticity and neurodegenerative disorders , 1999, Journal of neuroscience research.

[3]  M. Cuzner,et al.  Apoptotic Pathways Mobilized in Microglia and Neurones as a Consequence of Chromogranin A‐Induced Microglial Activation , 1999, Journal of neurochemistry.

[4]  T. Iwatsubo,et al.  Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease , 1998, Neuroscience Letters.

[5]  K. Arima,et al.  Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies , 1998, Brain Research.

[6]  R. Schiffer,et al.  A review of Lewy body disease, an emerging concept of cortical dementia. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[7]  D. Aunis,et al.  Chromogranin A Induces a Neurotoxic Phenotype in Brain Microglial Cells* , 1998, The Journal of Biological Chemistry.

[8]  Rena Li,et al.  Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain , 1997, Brain Research.

[9]  D. Walker,et al.  Neurons express proteins of the classical complement pathway in Alzheimer disease , 1997, Brain Research.

[10]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[11]  Y Agid,et al.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[13]  P. Mcgeer,et al.  Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease , 1996, Brain Research.

[14]  P. Lantos,et al.  Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease , 1996, Neuroscience Letters.

[15]  D. Aunis,et al.  Chromogranin a triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells , 1996, Neuroscience.

[16]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[17]  H. Akiyama,et al.  A pathological study of Lewy bodies and senile changes in the amygdala in diffuse Lewy body disease , 1995 .

[18]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[19]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[20]  P. Mcgeer,et al.  Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases , 1994, Neuroscience Letters.

[21]  J. Kimura,et al.  Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains , 1994, Brain Research.

[22]  D. Giulian,et al.  Brain glia release factors with opposing actions upon neuronal survival , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  J Q Trojanowski,et al.  Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. , 1991, The American journal of pathology.

[24]  D. Munoz,et al.  Chromogranin A-like immunoreactivity in the human brain: Distribution in bulbar medulla and cerebral cortex , 1990, Neuroscience.

[25]  P. Mcgeer,et al.  Brain microglia constitutively express β-2 integrins , 1990, Journal of Neuroimmunology.

[26]  C. Hagn,et al.  Chromogranins A, B, and C: Widespread Constituents of Secretory Vesicles a , 1987, Annals of the New York Academy of Sciences.

[27]  V. Tennyson,et al.  Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease , 1965 .